Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Reletrans 5micrograms/hour transdermal patches
0407020B0BKAAAH
|
Reletrans | Buprenorphine | Central Nervous System | 18,368 |
|
Reletrans 10micrograms/hour transdermal patches
0407020B0BKABAI
|
Reletrans | Buprenorphine | Central Nervous System | 17,592 |
|
Reletrans 20micrograms/hour transdermal patches
0407020B0BKADAJ
|
Reletrans | Buprenorphine | Central Nervous System | 9,232 |
|
Reletrans 15micrograms/hour transdermal patches
0407020B0BKACAK
|
Reletrans | Buprenorphine | Central Nervous System | 8,744 |
|
Reletrans 25microgram/hour transdermal patches
0407020B0BKAEAL
|
Reletrans | Buprenorphine | Central Nervous System | 207 |
|
Reletrans 30micrograms/hour transdermal patches
0407020B0BKAFAM
|
Reletrans | Buprenorphine | Central Nervous System | 141 |
|
Reletrans 40micrograms/hour transdermal patches
0407020B0BKAGAN
|
Reletrans | Buprenorphine | Central Nervous System | 56 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.